745 related articles for article (PubMed ID: 29684705)
41. Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy.
Nocentini A; Moi D; Balboni G; Salvadori S; Onnis V; Supuran CT
Bioorg Chem; 2018 Apr; 77():633-639. PubMed ID: 29502024
[TBL] [Abstract][Full Text] [Related]
42. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
[TBL] [Abstract][Full Text] [Related]
43. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
Soliman AM; Ghorab MM; Bua S; Supuran CT
Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
[TBL] [Abstract][Full Text] [Related]
44. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents.
Peerzada MN; Khan P; Ahmad K; Hassan MI; Azam A
Eur J Med Chem; 2018 Jul; 155():13-23. PubMed ID: 29852328
[TBL] [Abstract][Full Text] [Related]
46. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
[TBL] [Abstract][Full Text] [Related]
47. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer.
Eldehna WM; Nocentini A; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Reda AM; Abdel-Aziz HA; Supuran CT
Bioorg Chem; 2018 Dec; 81():425-432. PubMed ID: 30219719
[TBL] [Abstract][Full Text] [Related]
48. Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights.
Abdelrahman MA; Eldehna WM; Nocentini A; Bua S; Al-Rashood ST; Hassan GS; Bonardi A; Almehizia AA; Alkahtani HM; Alharbi A; Gratteri P; Supuran CT
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137489
[TBL] [Abstract][Full Text] [Related]
49. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
50. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.
Angapelly S; Sri Ramya PV; Angeli A; Supuran CT; Arifuddin M
ChemMedChem; 2017 Oct; 12(19):1578-1584. PubMed ID: 28940980
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
[TBL] [Abstract][Full Text] [Related]
52. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights.
Abo-Ashour MF; Eldehna WM; Nocentini A; Bonardi A; Bua S; Ibrahim HS; Elaasser MM; Kryštof V; Jorda R; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2019 Dec; 184():111768. PubMed ID: 31629164
[TBL] [Abstract][Full Text] [Related]
53. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors.
Said MA; Eldehna WM; Nocentini A; Bonardi A; Fahim SH; Bua S; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2020 Jan; 185():111843. PubMed ID: 31718943
[TBL] [Abstract][Full Text] [Related]
55. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
Lolak N; Akocak S; Bua S; Sanku RKK; Supuran CT
Bioorg Med Chem; 2019 Apr; 27(8):1588-1594. PubMed ID: 30846402
[TBL] [Abstract][Full Text] [Related]
56. Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors.
Kumar R; Bua S; Ram S; Del Prete S; Capasso C; Supuran CT; Sharma PK
Bioorg Med Chem; 2017 Feb; 25(3):1286-1293. PubMed ID: 28065499
[TBL] [Abstract][Full Text] [Related]
57. 4-Substituted benzenesulfonamides featuring cyclic imides moieties exhibit potent and isoform-selective carbonic anhydrase II/IX inhibition.
Abdel-Aziz AA; El-Azab AS; Ghiaty AH; Gratteri P; Supuran CT; Nocentini A
Bioorg Chem; 2019 Mar; 83():198-204. PubMed ID: 30380448
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII.
George RF; Said MF; Bua S; Supuran CT
Bioorg Chem; 2020 Jan; 95():103514. PubMed ID: 31887473
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
[TBL] [Abstract][Full Text] [Related]
60. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
